Effect of Age on Efficacy and Safety of Fluticasone Furoate/Vilanterol , and UMEC + FF/VI in Patients with Chronic Obstructive Pulmonary Disease: Analyses of Five Randomized Clinical Trials

Effect of Age on Efficacy and Safety of Fluticasone Furoate/Vilanterol , and UMEC + FF/VI in Patients with Chronic Obstructive Pulmonary Disease: Analyses of Five Randomized Clinical Trials

Introduction: Concerns have been raised about the practical use and clinical benefits of medications and inhalers in older patients with chronic obstructive pulmonary disease (COPD). Here, we report analyses according to age from five clinical trials evaluating medications administered using the ELL...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of chronic obstructive pulmonary disease 2021-07, Vol.16, p.1925
Hauptverfasser: Hanania, Nicola A, Caveney, Scott, Soule, Tedi, Tombs, Lee, Lettis, Sally, Crim, Courtney, Mannino, David M, Patel, Hitesh, Boucot, Isabelle H
Format: Artikel
Sprache:eng
Schlagworte:
Clinical trials
Lung diseases, Obstructive
Medical research
Medicine, Experimental
Respiratory agents
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Introduction: Concerns have been raised about the practical use and clinical benefits of medications and inhalers in older patients with chronic obstructive pulmonary disease (COPD). Here, we report analyses according to age from five clinical trials evaluating medications administered using the ELLIPTA dry-powder inhaler (DPI). Methods: Efficacy and safety according to age groups (
ISSN:1178-2005